Bugao, Lita L.

HRN: 02-15-26  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/13/2026
CEFTAZIDIME 1GM (VIAL)
02/13/2026
02/19/2026
IV
2gm
Q24
Pneumonia
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines